# Treatment of (IDA) by (FPC) Delivered Via Infusion Pump in Patients Receiving Home Infusion Therapy

> **NCT05110768** · PHASE2 · UNKNOWN · sponsor: **Rockwell Medical Technologies, Inc.** · enrollment: 75 (estimated)

## Conditions studied

- Iron Deficiency Anemia

## Interventions

- **DRUG:** Triferic AVNU
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05110768
- **Lead sponsor:** Rockwell Medical Technologies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-30
- **Primary completion:** 2022-04-30
- **Final completion:** 2022-05-30
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2021-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05110768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05110768, "Treatment of (IDA) by (FPC) Delivered Via Infusion Pump in Patients Receiving Home Infusion Therapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05110768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*